RNAimmune secures $27M in Series A financing | Maryland Dail

RNAimmune secures $27M in Series A financing | Maryland Daily Record

RNAimmune Inc., a biopharmaceutical company in Gaithersburg specializing in discovery and development of mRNA-based therapeutics and vaccines, announced Wednesday it has secured $27 million in a Series A round of financing. The company intends to use the funding to accelerate its research and development of mRNA vaccine and drug discovery focused on infectious disease, cancer, and ...

Related Keywords

California , United States , Los Angeles , Rnaimmune Inc , University Of California , Sirnaomics Ltd , Drug Administration , Boulder Fund , University Of Houston , Smooth River Limited , Rotating Boulder , Series Seed ,

© 2025 Vimarsana